Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer

Overview of attention for article published in Breast Cancer Research, October 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

So far, Altmetric has seen 7 patents that reference this research output.

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 3 additional patents.